Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/11/26 21:11 | 5/11/26 | ODTX | Health | BioPrd | Biological Products, (No Diag | Sr One Capital Management, LLC | CA | T | 1 | P.d | 10,000 | 18.00 | 0 | 556 | 17 | 3,795 | I | |||||||||||||||
5/11/26 20:35 | 5/8/26 | ODTX | Health | BioPrd | Biological Products, (No Diag | Leiden Jeffrey M | MA | D | 1 | P.d | 100 | 20.00 | 0 | 5 | 2 | 302 | M | |||||||||||||||
5/11/26 20:32 | 5/8/26 | ODTX | Health | BioPrd | Biological Products, (No Diag | Haas Jason | MA | O | CFO | 1 | P | 20 | 20.00 | 0 | 1 | 2 | 63 | D | ||||||||||||||
5/11/26 20:30 | 5/11/26 | ODTX | Health | BioPrd | Biological Products, (No Diag | Li Nan (Ln) | MA | D | 1 | P.d | 20,000 | 18.00 | 0 | 1,111 | 50 | 3,334 | I | |||||||||||||||
5/11/26 20:30 | 5/11/26 | ODTX | Health | BioPrd | Biological Products, (No Diag | Chu Shelley | MA | D | 1 | P | 200 | 18.00 | 0 | 11 | 11 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |